NCT00456157View on ClinicalTrials.gov

A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

November 30, 2008

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

Intra-articular Injection of OP-1 to affected knee

Trial Locations (3)

02111

Tufts-New England Medical Center, Boston

02118-2526

Boston University Medical Center, Boston

27599-7280

University of orth Carolina School of Medicine, Chapel Hill

All Listed Sponsors

lead

Stryker Biotech

INDUSTRY

NCT00456157 - A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter